Evaluating and Testing: COVID-19

On this page:

Forms

Collecting Specimens

Home Care Instructions

Guidance for evaluating, testing, and reporting COVID-19 in Minnesota.

Rapid IgM/IgG SARS-CoV-2 Tests (PDF)

Recommendations and testing concerns for clinics and health care providers.

4/7/20





Recommendations and testing concerns for clinics and health care providers. See Health Alert Network for advisories.

Updated 7/30/20

Current guidance for testing

In consideration of the testing priorities outlined below, evaluate how your staff resources and laboratory capacity can be used to ensure testing access for these priority groups. Individuals being tested for surveillance purposes (e.g., those tested prior to employment, for sports team or camp participation, enrollment in an academic institution) should not be prioritized for testing given nationwide reagent shortages and a lack of evidence to support the usefulness of a broad testing approach.

Testing Priorities

Symptomatic people

Symptomatic people in any setting. If PCR testing for SARS-CoV-2 is negative, symptomatic people should continue to self-isolate and follow setting-specific public health recommendations.



Asymptomatic people with either a known COVID-19 exposure or requiring medical care



Asymptomatic people requiring medical care

This includes patients where the procedure creates a high-risk for SARS-CoV-2 transmission (e.g., aerosol-generating procedures) or the procedure is high risk to the patient due to SARS-CoV-2 infection. Examples include: aerosol-generating procedure (e.g., intubation, bronchoscopy, etc.), or patients undergoing other procedures that may be delayed based on testing results (e.g., chemotherapy, cardiac surgery, or other procedures in which COVID-19 may worsen outcome), or patients admitted to the hospital.



Asymptomatic people linked to an ongoing public health investigation

Situations where one or more COVID-19 cases have been identified in a shared setting (e.g., long-term care facility, workplace, schools or child care, correctional facility). This type of testing should be done in consultation with MDH.



Asymptomatic people with a known COVID-19 exposure

If resources are limited, providers may consider further prioritizing testing to those contacts who would pose a significant risk of spread if they were infected or who are at high risk of severe disease. The following groups are considered highest priority: Individuals working or attending K-12 schools or child care.

Hospitalized patients.

Health care personnel.

First responders (e.g., EMS, law enforcement, firefighters).

Individuals living, working or visiting congregate settings.

Individuals with medical conditions including pregnancy.

Individuals 65 years of age and older.

Individuals who live in households with a higher risk individual or who provide care in a household with a higher risk individual

Member of a large household living in close quarters.

Exposure is defined as being within 6 feet for more than 15 minutes to persons with confirmed COVID-19. All close contacts should follow a 14-day quarantine period. Even if the result is negative, these contacts should continue to quarantine for a full 14 days after last exposure and monitor for symptoms; infection could develop at any time during the quarantine period. Repeat testing at the end of the quarantine period may be recommended for staff or residents of congregate settings (acute care, assisted living, skilled nursing, group homes, long-term care facilities, substance use disorder treatment centers, homeless shelters, and correctional facilities); refer to setting-specific testing guidance for additional information. Specific guidance is available for health care workers who have a health care exposure and these individuals should follow that guidance; it would apply if they have a community/household contact.

MDH Public Health Laboratory (PHL) testing priorities

Only send specimens to MDH-PHL for:

Symptomatic residents and staff in congregate living settings (long-term care facilities, prisons/jails, shelters for people experiencing homelessness, etc.).

Symptomatic dialysis patients.

Symptomatic patients that cannot be tested at an in-house lab, commercial lab, or through negotiated access to the University of Minnesota or Mayo Clinic labs.

Positive results from MDH will be communicated immediately to the provider. Negative and positive results will be faxed immediately to the submitting laboratory; please do not call us for the results. Results may not be available for up to 3 days. Please inform your patient of the result and do not have them call us for results.

Forms

COVID-19 Patient Testing Form (PDF)

Complete one form for each patient being tested. Include a copy with specimen submission.

Updated 4/23/20





Complete one form for each patient being tested. Include a copy with specimen submission. Forms for the Infectious Disease Laboratory

Clinical testing and submission forms for the MDH Public Health Laboratory.

Be sure to include project number 2618.

Collecting Specimens

Home Care Instructions

Health care providers should review with their patients the following CDC recommendations for the home care of patients being evaluated for COVID-19 who do not need to be hospitalized.

Please assist patients and household members with accessing personal protective equipment (disposable face masks and gloves).